Join us at HAX’s Deep Tech Showcase during NYC Deep Tech Week

Instant drug testing

GET CONNECTED
rxall.net

Team

Adebayo Alonge

CEO & Co-Founder

Amy Kao

CMO & Co-Founder

RxAll Inc.

Company details

RxAll is revolutionizing pharmacy financing and drug safety in the USA and Africa. RxAll can instantly detect counterfeit and fentanyl-laced medicines, while RxAll’s fintech platform helps pharmacies secure credit and optimize inventory. RxAll is creating safer pharmaceutical ecosystems and unlocking growth in the $30B+ African and $500B+ U.S. pharmacy markets.

Deep Tech 100Female FoundersPhysical AITherapeuticsUnited StatesSeedHard TechHealthcareHuman HealthHAX 2019

Company News

RxAll Named Honoree in Fast Company’s 2025 World Changing Ideas Awards | TechCabal

June 11, 2025
TechCabal

This tech is using AI to eliminate counterfeit prescription drugs – Fast Company

June 10, 2025

Nigerian Healthtech startup, RxAll, secures US$3.15mn funding

July 26, 2021
Get Funded Africa

RxAll grabs $3.1M to scale its drug checking and counterfeiting tech around Africa

July 20, 2021
TechCrunch

Nigerian Healthtech Startup, RxAll Secures N135m Investment from Founders Factory Africa

September 21, 2020
Technext

Get In Touch with RxAll Inc.

Please tell us a little bit about yourself and why you'd like to get connected. RxAll Inc. + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More